First Time Loading...

Meridian Bioscience Inc
NASDAQ:VIVO

Watchlist Manager
Meridian Bioscience Inc Logo
Meridian Bioscience Inc
NASDAQ:VIVO
Watchlist
Price: 33.97 USD Market Closed
Updated: May 13, 2024

Meridian Bioscience Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Meridian Bioscience Inc
Cash from Operating Activities Peer Comparison

Comparables:
COO
XRAY
ALGN
LNTH

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Meridian Bioscience Inc
NASDAQ:VIVO
Cash from Operating Activities
$82.4m
CAGR 3-Years
32%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Cooper Companies Inc
NYSE:COO
Cash from Operating Activities
$563.6m
CAGR 3-Years
4%
CAGR 5-Years
-5%
CAGR 10-Years
3%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Cash from Operating Activities
$423m
CAGR 3-Years
-16%
CAGR 5-Years
-2%
CAGR 10-Years
-1%
Align Technology Inc
NASDAQ:ALGN
Cash from Operating Activities
$785.8m
CAGR 3-Years
-4%
CAGR 5-Years
6%
CAGR 10-Years
15%
Lantheus Holdings Inc
NASDAQ:LNTH
Cash from Operating Activities
$324m
CAGR 3-Years
168%
CAGR 5-Years
35%
CAGR 10-Years
N/A

See Also

What is Meridian Bioscience Inc's Cash from Operating Activities?
Cash from Operating Activities
82.4m USD

Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's Cash from Operating Activities amounts to 82.4m USD.

What is Meridian Bioscience Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
15%

Over the last year, the Cash from Operating Activities growth was 23%. The average annual Cash from Operating Activities growth rates for Meridian Bioscience Inc have been 32% over the past three years , 15% over the past five years .